Key Takeaways
- Earnings surge on margin expansion: Q2 PAT rose 201.8% YoY to INR74.1 crores, driven by a 220 bps EBITDA margin jump to 8.8% and lower finance costs, even as H1 revenue fell 9.7% on supply chain disruptions.
- Structural tailwinds converging: Chinese competition is receding, anti-dumping duties and QCOs are gone, LDC advantages for Bangladesh/Vietnam expire next month, and domestic PTA capacity is coming, all supporting a sustained margin shift for integrated Indian players.
- Specialty capex approved with sharp payback: A INR200 crore investment in specialty filament and fiber targets a ~15% top-line lift, ~20% EBITDA growth, and a sub-2-year payback, with commercial operations expected within CY2027.
- Balance sheet rapidly deleveraging: Net debt fell 23.5% to ~INR852 crores, the debt-to-equity ratio improved from 2.18x to 1.31x, and H1 operating cash flow surged to INR328.5 crores from ~INR92 crores a year ago.
- What to watch next quarter: Whether the 9.9% H1 EBITDA margin holds through H2 as guided, the pace of PET chip utilization ramp-up from 60%, and any early export recovery as trade agreements take effect.
Profitability & Margin Drivers
- Product contribution and cost discipline: EBITDA margin expanded 220 bps to 8.8% in Q2 and 280 bps to 9.9% in H1, attributed to improved product contribution and continued attention to operating efficiency and cost.
- Raw material pass-through working: A 40% to 45% increase in raw material costs over the last half was fully passed on to customers with some margin improvement, and management expects that when prices come down, margins will be maintained.
- Crude price increase absorbed: The rise in crude to USD115 has been successfully passed on to customers, reflected in the 9.9% H1 margin.
- Eighth consecutive profitable quarter: The streak is credited to cost optimization completed, plants running well, and the INR628 crore investment in ramp-up and debottlenecking finished in FY23-24.
- Spread sustainability expected: Management hopes the 9.9% H1 EBITDA margin will be maintained in the next two quarters, with no big change seen.
Lohia: "Unless the double-digit margins will be there, nobody is going to invest. So margin has to go up for new investment to come."
Industry Structure & Competitive Shift
- Chinese competition receding: China is gradually exiting the commodity business, and yuan depreciation from INR12 early '25 to INR14.5 over the last one and a half years has made Chinese exports less competitive, reducing import pressure going forward.
- Policy tailwinds stacking up: Anti-dumping duty on PTA was withdrawn in the FY21 budget, QCO on China was imposed 2 to 2.5 years ago, and now textile trade agreements are coming, PTA plants are being built, and China/Vietnam are becoming uncompetitive, all converging to enable raw material cost pass-through.
- LDC advantage for competitors ending: Bangladesh and Vietnam had LDC duty advantages for 20 years, which expire in November next month itself, leveling the playing field for Indian producers.
- Cotton dynamics favor polyester: Cotton area has been stagnant for 30 years, cotton production stagnant for 7 years, and India is importing its highest-ever cotton this year, with cotton prices expected only to rise, supporting polyester demand as a substitute.
- No new polyester capacity before 2030: Greenfield projects take 3 to 4 years, and no capacity is in the pipeline currently; only once margins improve might capacity come, but that will take 3 to 4 years, not before 2030.
- India's integrated position underutilized: After China, India is the only country integrated across the full supply chain from refinery to naphtha to paraxylene to PTA and MEG, but has not been able to take advantage of it so far.
Lohia: "China is gradually is getting out of the commodity business and so the competition from China is not much there and because the currency devaluation in the last one and a half years, where compared to Chinese yuan, which was INR12 early '25, today is INR14.5. So Chinese competition is getting away and going forward, I do not see much Chinese competition and our margin may be maintained."
Volume & Utilization
- H1 volumes hit by supply chain: H1 total income fell 9.7% YoY to INR2,284 crores mainly due to supply chain issues, which management says are now resolved with no further impact expected from the current Middle East situation.
- PET chip utilization the drag: PSF and POY are running at 100% utilization, but the PET chip plant is operating at only 60%, dragging overall volumes lower; management is working to gradually ramp it up to 100%.
- FY27 volume guided lower: Full-year volume is expected around 4 lakh tonnes, down from 4.75 lakh tonnes in FY26 due to the H1 supply chain impact, with FY28 expected to recover to 4.75 lakh tonnes plus.
- Virgin vs recycled chip price gap: A decline in virgin PET chip prices relative to recycled chips may help increase PET chip volumes next year.
- Capacity utilization trajectory: Utilization has improved from 55% in FY24 to 58% in FY25 to 68% in FY26, as new facilities stabilized and market conditions improved.
Exports & Trade Agreements
- Export share collapsed: Exports dropped from 20% to 25% to just 6% in the last six months, because domestic demand rose and was more lucrative, and importing raw material from China to produce and export had become uncompetitive.
- Recovery thesis: With domestic PTA availability and trade agreements lowering duties, management is targeting a return to 20% to 25% export share.
- India-UK trade agreement live: Came into force in July 2026, creating opportunity for downstream textile customers.
- EU and US agreements in progress: India-EU FTA and US bilateral trade agreements are under negotiation, with a potential 10% duty advantage on garments expected to create much higher domestic demand, though the magnitude is unknown and will be clearer next year.
- DTY export margin potential: Once raw material availability increases, higher margins may be achievable in DTY exports because China, Taiwan, and Vietnam are becoming uncompetitive.
Domestic PTA & Raw Material Integration
- Domestic PTA capacity coming in 2027-28: IOCL's 0.12 crore tonne per annum plant at Paradip and GAIL's 0.12 crore tonne per annum plant at Mangalore are expected in 2027-28, which together with other plants will cover domestic demand of ~0.25 crore tonnes of imports and provide surplus.
- Margin benefit from local sourcing: Management expects a 2% to 3% gain from reduced imports when domestic PTA becomes available.
- Freight cost advantage: Indo Rama is the nearest customer to IOCL's Odisha plant with no market in eastern India, giving it a logistics advantage versus Gujarat-based industry; the Mangalore plant will also supply, and Reliance's plant will make Gujarat self-sufficient, directing Odisha and Mangalore output toward Indo Rama.
- Freight savings quantified: Potential 1.5% to 2% savings on freight, which management hopes for but says the exact situation will be known once the plants come in.
- Duty pass-through neutral: If duties come to zero, raw material duties also come to zero, so no net impact is expected.
Specialty Expansion & Capex
- INR200 crore investment approved: The board has approved approximately INR200 crores of additional investment across the company and its wholly owned subsidiary, Indorama Ventures Yarns Private Limited, for specialty filament and specialty fiber production at Butibori.
- Scope of expansion: Includes restarting a closed fiber line with extruders for hollow fiber production, adding extruders to filament machines for cationic, dope dyed, and colored yarns, and adding an extruder to the fiber line to make small-lot specialty products not possible with the current CP process.
- Financial projections: Based on current estimates, the expansion is expected to deliver ~15% growth in top line, ~20% growth in EBITDA, and a payback of less than 2 years, subject to execution, ramp-up, and market conditions.
- Incremental EBITDA timing: The INR100 crores of incremental EBITDA from this investment is expected in FY28-29.
- Funding mix: Through a combination of term loans and internal accruals.
- No downstream integration planned: Management has no plans to go further down the chain into fabrics or weaving at the moment.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Full-year EBITDA | INR400 crores plus (H1 already INR225 crores) | FY27 |
| Full-year turnover | Will exceed last year's turnover despite low Q1 | FY27 |
| Full-year volume | Around 4 lakh tonnes (down from 4.75 lakh tonnes in FY26) | FY27 |
| Volume recovery | Back to 4.75 lakh tonnes plus | FY28 |
| EBITDA margin | 9.9% H1 margin maintained; no big change seen | Next two quarters |
| Specialty expansion commercial operations | Within Calendar Year 2027 | CY2027 |
| Specialty expansion incremental EBITDA | INR100 crores | FY28-29 |
| PET chip utilization | Ramp up from 60% toward 100% gradually | No date (underway) |
| Export share recovery | Target 20% to 25% | Conditional on domestic PTA availability and trade agreements |
| Domestic PTA margin benefit | 2% to 3% gain from reduced imports | When domestic PTA becomes available (2027-28) |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| Total income | ₹1,344 cr, +10% YoY from ₹1,222 cr |
| EBITDA | ₹117.7 cr, +46.4% YoY from ₹80.4 cr |
| EBITDA margin | 8.8%, expanded 220 bps YoY from 6.6% |
| Profit after tax | ₹74.1 cr, +201.8% YoY from ₹24.6 cr |
| PAT margin | 5.5%, up from 2% YoY |
| Finance cost | ₹29 cr, down from ₹33.6 cr YoY |
| H1 FY27 total income | ₹2,284 cr, down 9.7% YoY from ₹2,531 cr |
| H1 FY27 EBITDA | ₹225.7 cr, +24.9% YoY from ₹180.7 cr |
| H1 FY27 EBITDA margin | 9.9%, expanded 280 bps YoY from 7.1% |
| H1 FY27 PAT | ₹137.8 cr, +78.3% YoY from ₹77.3 cr |
| H1 FY27 operating cash flow | ₹328.5 cr, vs approx. ₹92 cr in H1 FY26 |
| Net debt | ~₹852 cr as of Sep 30, 2026, down 23.5% from ₹1,113 cr at FY26-end |
| Debt-to-equity | 1.31x, improved from 2.18x at FY26-end |
| Trailing 12-month ROE | 38.2%, vs 33.85% at FY26-end |
| Trailing 12-month ROCE | 27%, vs 20.34% at FY26-end |
| Capacity utilization (FY26) | 68%, vs 58% in FY25 |
| FY27 volume expectation | ~4 lakh tonnes, vs ~4.75 lakh tonnes in FY26 |
| Exports share of revenue | 5.59%, down from 20–25% historically |
| Specialty expansion capex approved | ~₹200 cr, across company and subsidiary; commercial ops expected CY2027 |
| Expected top-line growth from capex | ~15%, with ~20% EBITDA growth, payback under 2 years |
| FY27 full-year EBITDA expectation | ₹400 cr plus, vs H1 FY27 EBITDA of ₹225.7 cr |
| PET chip plant utilization | 60%, while filament and fiber lines at 100% |
| Raw material price increase (last half) | 40–45%, passed on to customers with a lag of a week to 10 days |
| Crude price | $115 per barrel |
| Chinese yuan vs INR | ₹14.5, vs ₹12 in early 2025 |